Maternal diabetes and renal agenesis/dysgenesis

Erin M Davis1, Jennifer David Peck, David Thompson

  • 1The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.

Insights

Maternal diabetes significantly increases the risk of renal agenesis and dysgenesis in newborns. This study found a 3.1-fold higher odds of these congenital malformations in infants born to mothers with diabetes.

Area of Science:

  • Perinatology
  • Congenital Malformations
  • Epidemiology

Background:

  • Renal agenesis and dysgenesis are rare but severe congenital malformations affecting 2-5 infants per 10,000 live births.
  • Limited research exists on risk factors, particularly the association between maternal diabetes and renal malformations.

Purpose of the Study:

  • To investigate the association between maternal diabetes and the risk of renal agenesis/dysgenesis.
  • To evaluate diabetes as a potential risk factor for these specific congenital anomalies.

Main Methods:

  • A population-based case-control study was conducted in Texas from 2000-2002.
  • 89 cases of renal agenesis/dysgenesis were identified from the Texas Birth Defects Registry.
  • 356 controls were randomly selected and frequency matched to cases; maternal diabetes data was collected from vital records.

Main Results:

  • Deliveries to mothers with diabetes had 3.1 times greater odds of renal agenesis/dysgenesis compared to those without diabetes (95% CI, 1.1-9.3).
  • This association remained after controlling for matching factors.

Conclusions:

  • Findings support previous limited research linking maternal diabetes to renal agenesis/dysgenesis.
  • Maternal diabetes is suggested as a potential risk factor for congenital renal malformations, warranting further investigation into diabetes types.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...